PDA Webinar: Recent Breakthroughs in Gene Therapy Using AAV Delivered DNA

Ask a Question

The safe delivery of synthetic genetic material into the nuclei of patients’ cells requires creative approaches, such as Adeno Associated Viruses (AAV). This webinar, featuring two industry expert speakers, will look at the latest developments in the AAV manufacturing technology, and the most recent success story of this exciting new class of products – gene therapy.

Following the presentations, get your questions answered during a live 30-minute Q&A session with the speakers.

This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month.

Standard Registration

Member Price


GovernmentMember Only


Health AuthorityMember Only


AcademicMember Only




See Qualifying Criteria for Member Types.

Day 1

11:00 a.m. – 11:30 a.m.
rAAV Vector Development and Large-Scale Manufacturing Using BEVS Technology
Scott Jeffers, UniQure

11:30 a.m. – 12:00 p.m.
Strategic Process Development for Gene Therapy Vectors
Rob Tenerowicz, Group Vice President, Global Supply and Planning, BioMarin Pharmaceutical Inc.

12:00 p.m. – 12:30 p.m.
Q&A with Speakers

Agenda is subject to change.

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.